The federal judge considering drug manufacturer Sanofi’s motion for protection from 340B dispute resolution proceedings wants to hear more about a different court's recent decision to grant Eli Lilly such protection.

340B Dispute Resolution Injunction Is Having Ripple Effects

The federal judge considering drug manufacturer Sanofi’s motion for protection from 340B dispute resolution proceedings asked the company and the federal government last Wednesday to brief her on a different federal judge’s order the day before granting drug company Eli Lilly the same protection that Sanofi wants.

Sanofi and the government responded jointly on Sunday. They asked Chief Judge Freda L. Wolfson of U.S. District Court for the District of New Jersey to temporarily suspend Sanofi’s request for a preliminary injunction to stop the U.S. Health and Human Services Department (HHS) from convening 340B administrative dispute resolution (ADR) panels involving Sanofi.

The federal judge considering drug manufacturer Sanofi’s motion for protection from 340B dispute resolution proceedings asked the company and the federal government last Wednesday to brief her on a different federal judge’s order the day before granting drug company Eli Lilly the same protection that Sanofi wants.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer